Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

PRISMA flow chart. by Filip Stanicic (17808254)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

The framework of model parameter estimation based on GLUE and different combinations of observed data in this work. by Yonghui Zhang (279832)

Subjects:

Pearson’s correlation showing significant correlations (<i>P</i> < 0.05) between microbiota and clinical variables in the Staph group. by Paulo Kussek (13410476)

Contemporary mean inundation fraction in the Amazon basin. by Nic Gedney (19762301)

The table shows mean promastigote viability after drug treatment at various drug concentrations (‘-‘No live promastigotes observed under light microscope). by Harshita Sharma (4836180)

Subjects:

Changes of RMSEs (MAEs) with different combinations containing different number of observed phenological datasets for calibration. by Yonghui Zhang (279832)

Subjects:

Pulsed-pedestal task video demonstrates a trial in the pulsed-pedestal paradigm. by Xiaohua Zhuang (11890694)

Subjects:

An observer’s steady- and pulsed-pedestal threshold data and model fits: (1) steady-pedestal paradigm (MC pathway) non-flicker adaptation condition (open circle); (2) steady-pedest... by Xiaohua Zhuang (11890694)

Subjects:

Descriptive statistics for the free parameters. by Xiaohua Zhuang (11890694)

Subjects:

Fig 1 - by Xiaohua Zhuang (11890694)

Subjects:

Steady-pedestal task video demonstrates a trial in the steady-pedestal paradigm. by Xiaohua Zhuang (11890694)

Subjects:

S1 Data - by Xiaohua Zhuang (11890694)

Subjects:

Fig 3 - by Xiaohua Zhuang (11890694)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

Percentage of US adults with health insurance coverage by income-level, age 60 to 70 years. by Rahul Aggarwal (4428457)

Subjects:

Observed max. by Anika Liu (8411805)

Subjects:

Evaluation results of the calibration data from the different observed data combinations in Exp.1 and Exp. 3. by Yonghui Zhang (279832)

Subjects: